SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in BBNX — Beta Bionics, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in BBNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$134,548 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Common Shares in BBNX Over Time
Shares Held
Position Value (USD)
Derivatives in BBNX
reported options exposure · as of Jun 30, 2026CallValue
$432,492
CallShares
27,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $393,151,381 across 79 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
826,420 | $74,989,349 | |
| 2 | BSX |
Boston Scientific Corp
|
1,661,950 | $70,932,025 | |
| 3 | DXCM |
Dexcom Inc
|
1,043,864 | $70,304,239 | |
| 4 | MDT |
Medtronic plc
|
410,840 | $32,140,013 | |
| 5 | SYK |
Stryker Corp
|
76,719 | $24,154,209 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
314,867 | $20,154,636 | |
| 7 | TMDX |
TransMedics Group, Inc.
|
255,398 | $16,963,535 | |
| 8 | PEN |
Penumbra Inc
|
29,149 | $9,203,796 |
All Filings in BBNX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $432,492 | 27,600 | Call | Other | 2026-08-14 | |
| 2026-03-31 | $134,548 | 13,428 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $451,961 | 14,833 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $225,912 | 15,516 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $194,664 | 15,904 | Shares | Other | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||